CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 82 filers reported holding CARA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,000 | -66.7% | 149 | -63.6% | 0.00% | – |
| Q2 2021 | $6,000 | -33.3% | 409 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $9,000 | +50.0% | 409 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | +20.0% | 409 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | 0.0% | 409 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | -54.5% | 409 | -40.2% | 0.00% | 0.0% |
| Q4 2019 | $11,000 | -21.4% | 684 | -10.4% | 0.00% | -50.0% |
| Q3 2019 | $14,000 | +40.0% | 763 | +56.4% | 0.00% | +100.0% |
| Q2 2019 | $10,000 | -28.6% | 488 | -55.6% | 0.00% | -66.7% |
| Q4 2018 | $14,000 | – | 1,100 | +2650.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 40 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000,000 | +49900.0% | 40 | -84.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |